ConductScience.org, home

Paper33166307

Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.

Siddall H and 7 others. PLoS One, 2020. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study. Papers, record 33166307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33166307

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
PubMed
Journal
PLoS One
PubMed
Year
2020
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2020-12-23
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Siddall HHilaryhttps://orcid.org/0000-0002-3134-0855
2Quint DDiana
3Pandya HHitesh
4Powley WWill
5Shabbir SShaila
6Hohlfeld JMJens M
7Singh DDave
8Lee LLaurie

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenineMajor topic
AsthmaMajor topic
PiperidinesMajor topic
Toll-Like Receptor 7Major topic
Administration, Intranasal
Adult
Allergens
Anti-Asthmatic Agents
Bronchial Provocation Tests
Double-Blind Method
Female
Forced Expiratory Volume
Humans
Interferon-alpha
Male
Middle Aged
Proof of Concept Study
Rhinitis, Allergic
Young Adult

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02833974Effect of the GSK2245035 on the Allergen-induced Asthmatic ResponseBackgroundYes

Source ClinicalTrials.gov

Download CSV of trials

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119769993Chronic inflammation and asthma.Mutat Res2010https://conductscience.org/library/papers/19769993PubMed
225981191Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.N Engl J Med2015https://conductscience.org/library/papers/25981191PubMed
330275843Asthma.Allergy Asthma Clin Immunol2018https://conductscience.org/library/papers/30275843PubMed
415817806ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.Am J Respir Crit Care Med2005https://conductscience.org/library/papers/15817806PubMed
521867534Treatment of allergic asthma: modulation of Th2 cells and their responses.Respir Res2011https://conductscience.org/library/papers/21867534PubMed
628933516Anti-IL5 therapies for asthma.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28933516PubMed
726044169Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement.Clin Pharmacol Ther2015https://conductscience.org/library/papers/26044169PubMed
817400732Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17400732PubMed
925740945TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.J Immunol2015https://conductscience.org/library/papers/25740945PubMed
10589783Allergen-induced increase in non-allergic bronchial reactivity.Clin Allergy1977https://conductscience.org/library/papers/589783PubMed
1128681506Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.Clin Exp Allergy2017https://conductscience.org/library/papers/28681506PubMed
1231856838Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.Respir Res2019https://conductscience.org/library/papers/31856838PubMed
1326861551
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.
J Med Chem2016https://conductscience.org/library/papers/26861551PubMed
1420224068Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma.Am J Respir Crit Care Med2010https://conductscience.org/library/papers/20224068PubMed
1530792118Biological treatments for severe asthma: A major advance in asthma care.Allergol Int2019https://conductscience.org/library/papers/30792118PubMed
1630178633Regulatory T cells and asthma.J Zhejiang Univ Sci B2018https://conductscience.org/library/papers/30178633PubMed
1723125414Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist.J Immunol2012https://conductscience.org/library/papers/23125414PubMed
1817845579The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies.Allergy2007https://conductscience.org/library/papers/17845579PubMed
1922561835Asthma phenotypes: the evolution from clinical to molecular approaches.Nat Med2012https://conductscience.org/library/papers/22561835PubMed
2024119772Inhaled allergen bronchoprovocation tests.J Allergy Clin Immunol2013https://conductscience.org/library/papers/24119772PubMed

See all 23 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42052154Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights.Immun Inflamm2026https://conductscience.org/library/papers/42052154PubMed
39051512Dysfunction of dendritic cells in tumor microenvironment and immunotherapy.Cancer Commun (Lond)2024https://conductscience.org/library/papers/39051512PubMed
37426425When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment.Front Mol Biosci2023https://conductscience.org/library/papers/37426425PubMed
36964157Pathogenesis of allergic diseases and implications for therapeutic interventions.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36964157PubMed
35911708The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.Front Immunol2022https://conductscience.org/library/papers/35911708PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33166307

GET https://conductscience.org/api/papers/v1/33166307/references?page=2